By NewsDesk  @bactiman63 GlaxoSmithKline announced that the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend...

NewsDesk  @infectiousdiseasenews The UK Health Security Agency announced that as of September 1, the Shingrix vaccine will be available for people who are 70 to 79 years of age with weakened immune systems...

NewsDesk @bactiman63 GlaxoSmithKline today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes...

With the nation focused on the delivery of a COVID vaccine, the CDC wants to ensure that older individuals are protected against other prevalent yet preventable diseases that can lead to severe health...

Earlier this week, Senate Minority Leader, Chuck Schumer of New York made a statement concerning the shortage of the popular shingles vaccine, Shingrix and seemed to link it to the current government...

A new and more effective herpes zoster (shingles) vaccine, Shingrix®, is now available in all Albertsons Companies pharmacies across the United States. Shingrix® was recently approved by the FDA and...

One week after Canadian officials approved GlaxoSmithKline’s shingles vaccine, Shingrix, the US Food and Drug Administration (FDA) gave the vaccine it’s approval. The FDA on Friday approved...

GlaxoSmithKline announced Friday that Shingrix has been approved in Canada for the prevention of shingles (herpes zoster) in people aged 50 years or older. Shingrix is a non-live, recombinant subunit...

GlaxoSmithKline announced Wednesday that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the US Food and Drug Administration (FDA) voted unanimously that the data support...

GlaxoSmithKline  announced this week that it has submitted a Biologics License Application (BLA) for its candidate shingles vaccine, ShingrixTM, to the United States Food and Drug Administration (FDA),...